Evolution of Depression Management: Where have we been? Where are we going? And what role will Psychedelics play? Special Guest Dr. Alan Schatzberg

New Perceptions

English - June 17, 2020 15:00 - 50 minutes - 57.8 MB
Medicine Health & Fitness Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Author Interview: Tyler Kjorvestad, M.D. and Joseph Pullara, M.D.

Next Episode: Treatment-Resistant Depression: What is the role of Ketamine, DBS, VNS, TMS, and Psychedelics? Special Guest Dr. Scott Aaronson

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Alan Schatzberg.

Dr. Alan Schatzberg obtained his M.D. from NYU School of Medicine in 1968 and completed his Residency in Psychiatry in 1972 at The Massachusetts Mental Health Center. He has previously served as the 136thPresident of the American Psychiatric Association and was the Chair of Psychiatry Department at Stanford University from 1991-2010. He currently serves as a Professor of Psychiatry and Behavioral Sciences at Stanford University and is the Director of the Stanford Mood Disorders Center

Referenced Articles on Depression and Psychedelics:

Some Comments on Psychedelic Research: https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2020.20030272

A Word to the Wise about Ketamine: https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2014.13101434?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

---

Support this podcast: https://podcasters.spotify.com/pod/show/journalofpsychedelic/support

Twitter Mentions

@psychedelic_org